2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors

摘要

The present invention is directed to a solid dosage form for oral administration comprising novel inhibitors of the BACE1 enzyme and at least one pharmaceutically acceptable carrier.